MSLN and neoplasm: Preliminary findings from Zhao et al. showed that DNAX-activating protein 10 co-stimulation enhanced the anti-tumor efficacy of Msln-CAR T cell in NSCLC CDX and patient-derived xenograft (PDX) models (25).